Detailed Information

Cited 17 time in webofscience Cited 23 time in scopus
Metadata Downloads

Risk Factors for Developing Hyponatremia During Terlipressin Treatment A Retrospective Analyses in Variceal Bleeding

Authors
Yim, Sun YoungSeo, Yeon SeokJung, Chang HoKim, Tae HyungKim, Eun SunKeum, BoraKim, Ji HoonAn, HyongginYim, Hyung JoonYeon, Jong EunJeen, Yoon TaeLee, Hong SikChun, Hoon JaiByun, Kwan SooUm, Soon HoKim, Chang DuckRyu, Ho Sang
Issue Date
Aug-2015
Publisher
Lippincott Williams & Wilkins Ltd.
Keywords
body mass index; hyponatremia; variceal bleeding; terlipressin
Citation
Journal of Clinical Gastroenterology, v.49, no.7, pp.607 - 612
Indexed
SCIE
SCOPUS
Journal Title
Journal of Clinical Gastroenterology
Volume
49
Number
7
Start Page
607
End Page
612
URI
https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/7653
DOI
10.1097/MCG.0000000000000217
ISSN
0192-0790
Abstract
Goals: The aim of this study was to evaluate the risk factors and clinical significance of terlipressin-induced hyponatremia. Background: Patients receiving terlipressin treatment frequently develop hyponatremia. However, its clinical significance and risk factors are not fully elucidated. Study: Records of patients treated with terlipressin for variceal bleeding were analyzed. Hyponatremia was defined as a decrease in serum sodium (Na) level of >5 mEq/L from the baseline level; severe hyponatremia as a decrease in serum Na level of >10 mEq/L from the baseline level; and rapid severe hyponatremia as a decrease in serum Na level of >10 mEq/L within 3 days of treatment. Results: The study involved 151 patients (mean age, 55.1±11.8 y) with male predominance (80.8%). Baseline serum Na and creatinine levels were 137.2±6.1 mEq/L and 0.9±0.4 mg/dL, respectively. Patients were treated with terlipressin for 4.5±1.9 days. Changes in serum Na levels from baseline were 0.4±4.1, −1.1±4.8, −4.0±7.0, −6.5±9.1, and −6.1±11.2 mEq/L, whereas the frequencies of hyponatremia and severe hyponatremia were 13.6%, 30.4%, 50.8%, 63.5%, and 66.9% and 0%, 8.8%, 23.3%, 33.0%, and 38.8% on days 1, 2, 3, 4, and 5 of treatment, respectively. Younger age, lower Child-Pugh score, higher serum Na level, and longer duration of terlipressin treatment were independent risk factors. Rapid severe hyponatremia developed in 29 patients (19.2%); lower body mass index was an additional risk factor in this group. Mortality was not associated with hyponatremia. Conclusions: Terlipressin-induced hyponatremia occurred frequently, especially in young patients with good liver function and higher Na level. Caution is required when administering terlipressin to patients with low body mass index.
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Internal Medicine > 1. Journal Articles
1. Basic Science > Department of Biostatistics > 1. Journal Articles
2. Clinical Science > Department of Gastroenterology and Hepatology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Lee, Hong Sik photo

Lee, Hong Sik
안암병원 (Department of Gastroenterology and Hepatology, Anam Hospital)
Read more

Altmetrics

Total Views & Downloads

BROWSE